Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marge Kartau

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Brain and Behavior|February 20, 2024
Plasma antioxidant potential measured by total radical trapping antioxidant parameter in a cohort of multiple sclerosis patientsMarge Kartau, Joonas Kartau, Marjatta Pohja, et al.
Degenerative Neurological and Neuromuscular Disease|December 11, 2019
Progressive Multifocal Leukoencephalopathy: Current InsightsMarge Kartau, Jussi Ot Sipilä, Eeva Auvinen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 9, 2021
JC polyomavirus DNA detection in clinical practiceMarge Kartau, Eeva Auvinen, Auli Verkkoniemi-Ahola, et al.
Open Forum Infectious Diseases|March 1, 2019
The Incidence and Predisposing Factors of John Cunningham Virus-Induced Progressive Multifocal Leukoencephalopathy in Southern Finland: A Population-Based StudyMarge Kartau, Auli Verkkoniemi-Ahola, Anders Paetau, et al.
Frontiers in Aging Neuroscience|January 23, 2023
Neurofilament light level correlates with brain atrophy, and cognitive and motor performanceMarge Kartau, Susanna Melkas, Joonas Kartau, et al.
Journal of Neurology|July 13, 2021
Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patientsIlkka Rauma, Tiina Mustonen, Juha Matti Seppä, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Brain and Behavior|February 20, 2024
Plasma antioxidant potential measured by total radical trapping antioxidant parameter in a cohort of multiple sclerosis patientsMarge Kartau, Joonas Kartau, Marjatta Pohja, et al.
Degenerative Neurological and Neuromuscular Disease|December 11, 2019
Progressive Multifocal Leukoencephalopathy: Current InsightsMarge Kartau, Jussi Ot Sipilä, Eeva Auvinen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 9, 2021
JC polyomavirus DNA detection in clinical practiceMarge Kartau, Eeva Auvinen, Auli Verkkoniemi-Ahola, et al.
Open Forum Infectious Diseases|March 1, 2019
The Incidence and Predisposing Factors of John Cunningham Virus-Induced Progressive Multifocal Leukoencephalopathy in Southern Finland: A Population-Based StudyMarge Kartau, Auli Verkkoniemi-Ahola, Anders Paetau, et al.
Frontiers in Aging Neuroscience|January 23, 2023
Neurofilament light level correlates with brain atrophy, and cognitive and motor performanceMarge Kartau, Susanna Melkas, Joonas Kartau, et al.
Journal of Neurology|July 13, 2021
Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patientsIlkka Rauma, Tiina Mustonen, Juha Matti Seppä, et al.
Pageof 1